Virtus ETF Advisers LLC - AUTOLUS THERAPEUTICS PLC ownership

AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 67 filers reported holding AUTOLUS THERAPEUTICS PLC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
Virtus ETF Advisers LLC ownership history of AUTOLUS THERAPEUTICS PLC
ValueSharesWeighting
Q1 2022$115,000
-23.8%
27,536
-5.6%
0.05%
-10.5%
Q4 2021$151,000
-11.2%
29,175
+2.6%
0.06%
-18.6%
Q1 2020$170,000
-60.5%
28,428
-12.7%
0.07%0.0%
Q4 2019$430,000
+110.8%
32,577
+98.7%
0.07%
+70.7%
Q3 2019$204,000
-26.9%
16,398
-5.3%
0.04%
-30.5%
Q2 2019$279,000
+5.3%
17,311
+105.3%
0.06%
-89.5%
Q1 2019$265,000
-15.1%
8,434
-11.2%
0.56%
+964.2%
Q4 2018$312,0009,5020.05%
Other shareholders
AUTOLUS THERAPEUTICS PLC shareholders Q2 2022
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 3,530,657$23,126,0001.85%
TFG Asset Management GP Ltd 2,500,000$16,375,0001.00%
Nantahala Capital Management 2,936,791$19,236,0000.61%
MYDA Advisors LLC 171,953$1,126,0000.32%
SABBY MANAGEMENT, LLC 300,000$1,965,0000.27%
Regency Capital Management Inc.\DE 57,000$373,0000.26%
Ikarian Capital, LLC 544,819$3,568,0000.25%
Eversept Partners, LP 398,074$2,607,3850.18%
Henry James International Management Inc. 54,047$354,0000.11%
Alphabet Inc. 698,262$4,574,0000.11%
View complete list of AUTOLUS THERAPEUTICS PLC shareholders